NCT02068755|Completed
Blood Products in Cardiac Surgery
BiCS
The Use of Blood Products in Patients Undergoing Cardiac Surgery
Loading search results
BiCS
The Use of Blood Products in Patients Undergoing Cardiac Surgery
Sponsor study identifier
observational
31,000
0 countries
N/A
Study Start
January 2002
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
December 2012
Actual (reported)Study Completion
December 2012
Actual (reported)Blood transfusion is a common procedure essential for the treatment of patients undergoing cardiac surgery. Inappropriate transfusions, however, not only incur needless healthcare costs, but increase unnecessary risks due to transfusion reactions and infectious and immunomodulative causes. Safe and appropriate patient care requires evaluated blood component prescription practices. Practically all patients undergoing cardiac surgery in Finland have a blood product booking from the Finnish Red Cross Blood Service. This registry contains large volumes of transfusion-related information on all Finnish patients undergoing cardiac surgery in Finnish centers. Participating hospitals were scattered to all geographical areas in Finland and concentrated to the most populated regions. Data on the blood product use, laboratory findings one month pre-operatively and 12 months post-operatively were available. Finnish hospitals have been required to provide information on hospital visits for the Finnish National Research and Development Centre for Welfare and Health for healthcare planning purposes. We used in part the original data sent by hospitals to the Finnish Hospital Discharge Register (FHDR).
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
December 2012
Actual (reported)Click on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
January 2002
Date type not reportedThis date has not been verified as actual or estimated.
December 2012
Actual (reported)December 2012
Actual (reported)February 19, 2014
Actual (reported)February 21, 2014
Actual (reported)Red blood cell infusions
12 months
Platelet infusion
12 months
Fresh frozen plasma
12 months
Octaplas
12 months
Patients who have undergone cardiac surgery
We collected data from patients who visited underwent cardiac surgery in Finnish hospitals during the years 2002 and 2012. Participating perform all the cardiac surgery in Finland and hospitals were scattered to all geographical areas in Finland.
Pirjo Mustonen, MD, PhD
Central Finland Hospital District
Juhani Airaksinen, Prof
Turku University Hospital and University of Turku
Fausto Biancari, MD, PhD
Oulu University Hospital
Tuomas O Kiviniemi, Md, PhD
Turku University Hospital and University of Turku
31,000 participants (actual enrollment reported by the registry).
First Submitted
February 19, 2014
First Posted
February 21, 2014
Study Start
January 2002
Date type not reportedThis date has not been verified as actual or estimated.
Efficacy and Safety of Venofer (Iron Sucrose Injection USP) in Patients Receiving Peritoneal Dialysis
All cause mortality
12 months
myocardial infarction
12 months
TIA/stroke/arterial embolism
12
re-operation due to bleeding
12 months
Contact the study team to confirm eligibility.
Primary Completion
December 2012
Actual (reported)Study Completion
December 2012
Actual (reported)Last Updated
February 21, 2014
Record last verified: 2014-02
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: